Hair Growth Stimulating Lotion

€34,95 EUR

*When you order 3 Hair Growth Stimulating Lotions you receive a free Hair Growth Enhancing Scalp Roller

Quantity 2 products 3 products
Discount % 10% 15%
Description Neofollics Hair Growth Stimulating Lotion

The Neofollics Hair Growth Stimulating Lotion, with 7% Neoxyl is the most powerful lotion on the market to stimulate hair growth. The Neoxyl hair growth complex contains 10 scientifically proven ingredients to stimulate the hair growth.

How the Neofollics Hair Growth Lotion works

The Neofollics Lotion is applied directly to the scalp. The Efficacy Booster™ ensures an effective absorption that is non-sticky and pleasant to use.

The Neofollics Lotion is researched in several clinical studies. These studies show a positive effect on stimulating hair growth, inhibiting hair loss and the density of the hair. Furthermore, 92% of users indicate that they see an improvement in hair growth.

At Neofollics we frequently collaborate with dermatologists, hair specialists and trichologists to ensure the quality and effectiveness of our products. This is also the reason that Neofollics products are produced in the Netherlands.

In conclusion, the Neofollics lotion is the most powerful lotion on the market to stimulate hair growth.

Content Neofollics Lotion

The Neofollics Lotion contains 90ml Hair Growth Stimulating Lotion, sufficient for 1 - 2 months of use depending on the dosage. The Lotion contains 7% Neoxyl® which consists of 10 active ingredients. The hair growth complex Neoxyl® also contains 6 powerful plant extracts and peptides. This not only stimulates hair growth, but also improves the condition of the scalp.

For who is the Neofollics Lotion suitable?

The Neofollics Lotion is suitable for every man and woman (18+) who want to effectively improve and stimulate the condition of the hair. Furthermore, the lotion is also a suitable solution to stop hair loss.

Suitable product with:
  • (Extreme) hair loss
  • Thinning hair
  • A rising hairline
  • Cove formation
  • Alopecia Areata
  • Androgenetic Alopecia
  • Telogen Effluvium
  • Hair loss after pregnancy
  • Hair loss during menopause

In short, the Neofollics lotion is suitable with almost all types of hair loss.

The experiences with the Neofollics Hair Growth Stimulating Lotion

A lot of people have positive experiences with the Neofollics lotion. Most users see improvement in their hair condition after 3 months of using the Neofollics Lotion. So if you want to stimulate your hair growht and stop your hairloss, add the Neofollics Lotion to the shopping cart and order it today.

The Neofollics Lotion is a topical spray that can be used on the scalp twice a day. The recommended dose is 2 times 10 sprays (morning & evening).

  • Crown: 3 sprays
  • Coves: 2 sprays left & 2 sprays right
  • Top: 3 sprays

Apply the lotion directly to the scalp or to the fingertips/hands first. Massage the lotion into the affected area on the scalp well. The lotion should not be washed out for 4 hours. The use of styling products such as gel and wax is possible. Allow the lotion to soak in first so that it cannot be diluted by styling products.

The use of Neofollics Lotion during pregnancy is not recommended for women.

Aqua, Pyrrolidinyl Diaminopyrimidine Oxide, Polysorbate 20, PEG-12 Dimethicone, Alcohol Denat, Diaminopyrimidine Oxide, Ecklonia Cava Extract, Adenosine, Raspberry Ketone, Carthamus Tinctorius Flower Extract, Sanguisorba Officinalis Root Extract, Camellia Sinensis Leaf Extract (EGCG), Sodium Hyaluronate, Lecithin (Liposomes), Copper Tripeptide-1, Aminomethyl Propanol, Glycerin, Sodium Benzoate, Panthenol, Citric Acid, DMDM Hydantoin, Potassium Sorbate

Find the science on our products below.

Studies on hair growth molecules:

Vividine: Study 1

Aminexil: Study 1, Study 2

Adenosine: Study 1Study2, Study 3, Study 4

Studies on plant extracts:

Ecklonia cavaStudy 1, Study 2

Raspberry ketone: Study 1

Carthamus tinctorius: Study 1, Study 2

Sanguisorba officinalisStudy 1

Proanthocyanidine B2: Study 1

EGCG: Study 1

Copper tripeptide-1: Study 1